Connect with us

Hi, what are you looking for?

Tech & Science

Coronavirus: How we respond to the vaccine differs if we have had a prior infection

The vaccine had a greater effect on those who had not previously been infected.

Hospital Corpsman 1st Class Diana Rodriguez administers a smallpox vaccine to a patient on the mess decks of the Nimitz-class aircraft carrier USS John C. Stennis (CVN 74) during immunizations in 2012. Source - US Navy/MC3 Kenneth Abbate/USS JOHN C. STENNIS (CVN 74)/U.S. Navy. Public Domain
Hospital Corpsman 1st Class Diana Rodriguez administers a smallpox vaccine to a patient on the mess decks of the Nimitz-class aircraft carrier USS John C. Stennis (CVN 74) during immunizations in 2012. Source - US Navy/MC3 Kenneth Abbate/USS JOHN C. STENNIS (CVN 74)/U.S. Navy. Public Domain

Researchers are continuing to unravel information about the coronavirus and the variations in terms of reactions in the human body. Such research is where immunology and inflammation studies meet microbiology and infectious disease inquiries.

Considerable work has been undertaken to study the antibodies produced in response to COVID-19 vaccines, medical researchers ae less clear about the response by the immune system’s T cells.

T-cells are a part of the body’s immune system and they focus on specific foreign particles. Instead of generically attack any antigens, as with other parts of the immune system, T-cells circulate until they encounter their specific antigen. This means T-cells play a critical part in immunity to foreign substances.

It follows that T-cells are important in relation to the coronavirus by offering longer-term protection against SARS-CoV-2.

A new insight into some variations with T-cells comes from scientists from Gladstone Institutes. Here, researchers have carried out a detailed survey of T-cells before and after COVID-19 immunisation.

Based on the data review, the scientists conclude that both the Pfizer and Moderna vaccines lead to the generation of long-term populations of T-cells that can recognise multiple variants of the SARS-CoV-2 virus.

While this development is positive, the researchers have also identified key differences in the T-cell responses of individuals who had been infected with COVID-19 prior to vaccination compared to those who had never been infected.

This leads one of the researchers, Nadia Roan, to state: “It’s not just the number of T cells that matter; It’s the quality—whether the T cells are the type that can actively destroy virus-infected cells.”

What the research showed was with people who had never been infected with SARS-CoV-2, it was found that the T cell response became stronger (quantity and quality of T cells) after the second vaccine dose. In contrast, with those who had previously had a COVID-19 infection, there was little change between the first and second dose of the vaccine. In other words, the vaccine had a greater effect on those who had not previously been infected and for those who had previously been effected, a lower lift was needed.

The new research of interest appears in the journal eLife, where it is titled: ‘mRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status’.

Written By

Dr. Tim Sandle is Digital Journal's Editor-at-Large for science news. Tim specializes in science, technology, environmental, and health journalism. He is additionally a practising microbiologist; and an author. He is also interested in history, politics and current affairs.

You may also like:

World

Eleven masterpieces by Pablo Picasso fetched $108.9 million at a Sotheby's auction in Las Vegas on Saturday. 

Life

It seems that Surgeon General Joseph Ladapo just can't keep his name out of the news spotlight.

World

The migrants began heading west and north toward the U.S. border, pushing past a line of state police who were trying to stop them.

World

Kyaw Min Yu pictured on his release from prison in 2012 - Copyright ${image.metadata.node.credit} ${image.metadata.node.creator}An activist who rose to prominence during Myanmar’s 1988 student...